Abstract
Granulomatosis with polyangiitis (GPA) is a form of vasculitis that affects small- and medium-sized vessels in many organs. The aim of the study was to describe the epidemiology of GPA in Poland in 2011–2015, including the incidence and prevalence rates. The authors conducted a retrospective, population-based study, using hospital discharge records with GPA diagnosis. GPA incidence was estimated on the basis of the data from the Polish hospital morbidity study carried out by the National Institute of Public Health. The final study group consisted of 1491 patients (749 females, 742 males) who were first time hospitalized with the diagnosis of GPA. The average annual incidence of GPA in Poland was 7.7/1,000,000 (95% CI, 4.1–11.4), and the point prevalence at the end of 2015 was 36/1,000,000. A statistically significant decrease in the GPA incidence was noticed in this study. A 1-year survival rate for GPA was 94%. In conclusion, the incidence and prevalence rates of GPA in Poland are similar to that reported in other European countries. The study provides recent epidemiological data on GPA in Poland, which may be useful for comparisons with other geographical regions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abramson JH (2011) WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov 8(1):1
Catanoso M, Macchioni P, Boiardi L, Manenti L, Tumiati B, Cavazza A, Luberto F, Pipitone N, Salvarani C (2014) Epidemiology of granulomatosis with polyangiitis (Wegener’s granulomatosis) in northern Italy: a 15-year population-based study. Semin Arthritis Rheum 44:202–207
CSO (2016) Central Statistical Office of Poland. http://stat.gov.pl. Accessed on 13 Oct 2016
Dadoniene J, Kirdaite G, Mackiewicz Z, Rimkevicius A, Haugeberg G (2005) Incidence of primary systemic vasculitides in Vilnius: a university hospital population based study. Ann Rheum Dis 64:335–336
de Zoysa JR (2013) Vasculitis in New Zealand. Clin Exp Nephrol 17:712–714
Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DRW, Scott DGI, Hashimoto H, Nunoi H (2011) Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatol Oxf Engl 50:1916–1920
Gibelin A, Maldini C, Mahr A (2011) Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and Goodpasture syndrome: vasculitides with frequent lung involvement. Semin Respir Crit Care Med 32:264–273
Gibson A, Stamp LK, Chapman PT, O’Donnell JL (2006) The epidemiology of Wegener’s granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatol Oxf Engl 45:624–628
Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, Rodriguez-Ledo P, Llorca J (2003) The epidemiology of the primary systemic vasculitides in Northwest Spain: implications of the Chapel Hill consensus conference definitions. Arthritis Rheum 49:388–393
Herlyn K, Hellmich B, Gross WL, Reinhold-Keller E (2008) Stable incidence of systemic vasculitides in Schleswig-Holstein, Germany. Dtsch Arztebl Int 105:355–361
Herlyn K, Buckert F, Gross WL, Reinhold-Keller E (2014) Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology 53:882–889
Hissaria P, Cai FZJ, Ahern M, Smith M, Gillis D, Roberts-Thomson P (2008) Wegener’s granulomatosis: epidemiological and clinical features in a south Australian study. Intern Med J 38:776–780
Hogan SL, Cooper GS, Savitz DA, Nylander-French LA, Parks CG, Chin H, Jennette CE, Lionaki S, Jennette JC, Falk RJ (2007) Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population–based, case-control study. Clin J Am Soc Nephrol 2:290–299
Kanecki K, Życińska K, Moskalewicz B, Tyszko P (2014) Granulomatosis with polyangiitis in Poland – epidemiological study. Reumatologia 52:99–104
Kanecki K, Nitsch-Osuch A, Gorynski P, Tarka P, Tyszko P (2017) Hospital morbidity database for epidemiological studies on Churg-Strauss syndrome. Adv Exp Med Biol 980:19–25
Khan AR, Chapman PT, Stamp LK, Wells JE, O’Donnell JL (2012) Wegener’s granulomatosis: treatment and survival characteristics in a high-prevalence southern hemisphere region. Intern Med J 42:23–26
Knight A, Sandin S, Askling J (2010a) Increased risk of autoimmune disease in families with Wegener’s granulomatosis. J Rheumatol 37:2553–2558
Knight A, Sandin S, Askling J (2010b) Occupational risk factors for Wegener’s granulomatosis: a case-control study. Ann Rheum Dis 69:737–740
Koldingsnes W, Nossent H (2000) Epidemiology of Wegener’s granulomatosis in northern Norway. Arthritis Rheum 43:2481–2487
Lane SE, Watts RA, Bentham G, Innes NJ, Scott DGI (2003) Are environmental factors important in primary systemic vasculitis? A case-control study. Arthritis Rheum 48:814–823
Langford C (2012) Clinical features and diagnosis of small-vessel vasculitis. Cleve Clin J Med 79(Suppl 3):3–7
Luqmani R, Suppiah R, Edwards CJ, Phillip R, Maskell J, Culliford D, Jayne D, Morishita K, Arden N (2011) Mortality in Wegener’s granulomatosis: a bimodal pattern. Rheumatol Oxf Engl 50:697–702
Mahr A, Guillevin L, Poissonnet M, Aymé S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51:92–99
Mahr AD, Neogi T, Merkel PA (2006a) Epidemiology of Wegener’s granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol 24(2 Suppl 41):82–91
Mahr A, Artigues N, Coste J, Aouba A, Pagnoux C, Guillevin L, French Vasculitis (2006b) Study group seasonal variations in onset of Wegener’s granulomatosis: increased in summer? J Rheumatol 33:1615–1622
Mohammad AJ, Jacobsson LTH, Westman KWA, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatol Oxf 48:1560–1565
O’Donnell JL, Stevanovic VR, Frampton C, Stamp LK, Chapman PT (2007) Wegener’s granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient. Intern Med J 37:242–246
Ormerod AS, Cook MC (2008) Epidemiology of primary systemic vasculitis in the Australian capital territory and south-eastern New South Wales. Intern Med J 38:816–823
Pamuk ÖN, Dönmez S, Calayır GB, Pamuk GE (2016) The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey. Clin Rheumatol 35:2063–2071
Pearce FA, Grainge MJ, Lanyon PC, Watts RA, Hubbard RB (2017) The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK Clinical Practice Research Datalink. Rheumatol Oxf 56:589–596
Romero-Gómez C, Aguilar-García JA, García-de-Lucas MD, Cotos-Canca R, Olalla-Sierra J, García-Alegría JJ, Hernández-Rodríguez J (2015) Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies. Clin Exp Rheumatol 33(2 Suppl 89):11–18
Takala JH, Kautiainen H, Malmberg H, Leirisalo-Repo M (2008) Incidence of Wegener’s granulomatosis in Finland 1981–2000. Clin Exp Rheumatol 26(3 Suppl 49):81–85
Tan JA, Dehghan N, Chen W, Xie H, Esdaile JM, Avina-Zubieta JA (2017) Mortality in ANCA-associated vasculitis: a meta-analysis of observational studies. Ann Rheum Dis 76:1566–1574
Wallace ZS, Lu N, Unizony S, Stone JH, Choi HK (2016) Improved survival in granulomatosis with polyangiitis: a general population-based study. Semin Arthritis Rheum 45:483–489
Wallace ZS, Lu N, Miloslavsky E, Unizony S, Stone JH, Choi HK (2017) Nationwide trends in hospitalizations and in-hospital mortality in granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res 69:915–921
Watts RA, Al-Taiar A, Scott DGI, Macgregor AJ (2009) Prevalence and incidence of Wegener’s granulomatosis in the UK general practice research database. Arthritis Rheum 61:1412–1416
Watts RA, MacGregor AJ, Mackie SL (2015) HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis. Rheumatol Oxf Engl 54:359–362
Conflicts of Interest
Authors declare no conflict of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Kanecki, K., Nitsch-Osuch, A., Gorynski, P., Tarka, P., Bogdan, M., Tyszko, P. (2018). Epidemiology of Granulomatosis with Polyangiitis in Poland, 2011–2015. In: Pokorski, M. (eds) Clinical Medicine Research. Advances in Experimental Medicine and Biology(), vol 1116 . Springer, Cham. https://doi.org/10.1007/5584_2018_239
Download citation
DOI: https://doi.org/10.1007/5584_2018_239
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-04836-5
Online ISBN: 978-3-030-04837-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)